Quaker Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
WAM
RFM
NHFG
MFS
LRPA
SGH
EWM
Quaker Wealth Management's XBI Position: Q2 2026 in Review
Quaker Wealth Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 291 shares worth $46.1K. The position accounts for 0.01% of the portfolio, ranked #172.
Quaker Wealth Management first reported a position in XBI in Q3 2024 and has held it in 6 quarters since. The position peaked at $4.78M in Q3 2024. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Quaker Wealth Management held 291 shares of State Street SPDR S&P Biotech ETF worth $46.1K as of Q2 2026.
- Quaker Wealth Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
- State Street SPDR S&P Biotech ETF made up 0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #172 holding.
- Quaker Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 6 quarters since.
- Quaker Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $4.78M in Q3 2024.
- 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.